**ROLE SUMMARY** VELSIPITY represents an exciting new launch opportunity within Specialty Care. The launch of VELSIPITY in October 2023 was an important milestone as Pfizer endeavors to expand its leadership in I&I. This new oral medicine supports patients with moderately to severely active Ulcerative Colitis, with a focus on patients in their first line of […]